Astera Labs (NASDAQ:ALAB – Get Free Report) is expected to issue its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect the company to announce earnings of $1.19 per share and revenue of $550.78 million for the quarter. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Investors may review the information on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 4:30 PM ET.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the previous year, the firm posted $0.44 EPS. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. On average, analysts expect Astera Labs to post $2.71 EPS for the current fiscal year and $4.56 EPS for the next fiscal year.
Astera Labs Price Performance
Shares of ALAB stock opened at $259.51 on Tuesday. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a market capitalization of $45.02 billion, a P/E ratio of 128.47 and a beta of 3.68. The company’s fifty day moving average price is $310.76 and its two-hundred day moving average price is $252.11.
Insider Transactions at Astera Labs
In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock valued at $127,306,034 over the last ninety days. 10.40% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on ALAB shares. Roth Capital restated a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Weiss Ratings cut Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday. Susquehanna boosted their price target on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Royal Bank Of Canada increased their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Finally, TD Cowen lowered their price objective on Astera Labs from $375.00 to $300.00 and set a “hold” rating for the company in a research note on Monday, October 19th. Eleven investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $340.79.
Read Our Latest Research Report on ALAB
Astera Labs Company Profile
Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.
See Also
- Five stocks we like better than Astera Labs
- A Solid Margin Story Means the Sell-Off in DECK May Be Overdone
- Verizon’s Q3 Results Show Why SpaceX’s Spectrum Grab Isn’t a Major Threat
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
